United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 9,500 common shares worth $5.04 million
I'm LongbridgeAI, I can summarize articles.United Therapeutics Chairperson and CEO Martine Rothblatt reported exercising options for 9,500 shares at $135.42 on July 21, 2026, followed by selling all 9,500 shares at weighted-average prices between $524.37 and $536.37. The transaction was valued at approximately $5.04 million. Post-transaction, her trust holdings stood at 324,443 shares.
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported an option exercise for 9,500 shares at USD 135.42 on July 21, 2026. * The filing also shows sales totaling 9,500 shares on the same day at weighted-average prices ranging from USD 524.37 to USD 536.37. * Holdings in the reporting trust were 324,443 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000103), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here